These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1212 related items for PubMed ID: 30370514

  • 21. Comparison of S-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single-center retrospective study.
    Jiang Z, Sun Y, Zhang W, Cui C, Yang L, Zhou A.
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):180-186. PubMed ID: 32077628
    [Abstract] [Full Text] [Related]

  • 22. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
    Lv JB, Yin YP, Zhang P, Cai M, Chen JH, Li W, Li G, Wang Z, Wang GB, Tao KX.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan 25; 26(1):84-92. PubMed ID: 36650004
    [Abstract] [Full Text] [Related]

  • 23. Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population.
    Dong S, Yu JR, Zhang Q, Liu XS.
    J Chemother; 2016 Jan 25; 28(1):59-64. PubMed ID: 25977986
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matching.
    Lv CB, Tong LY, Zeng WM, Chen QX, Fang SY, Sun YQ, Cai LS.
    World J Surg Oncol; 2024 Sep 11; 22(1):244. PubMed ID: 39256787
    [Abstract] [Full Text] [Related]

  • 25. Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysis.
    Wu L, Feng Y, Wu Z, Xu H, Zhang C, Ning J, Wang R, Chen J, Xie M, Zhang Y, Bu L, Hao J, Ma T.
    World J Surg Oncol; 2021 Sep 10; 19(1):272. PubMed ID: 34507562
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer.
    Wu Y, Wei ZW, He YL, Schwarz RE, Smith DD, Xia GK, Zhang CH.
    World J Gastroenterol; 2013 Jun 07; 19(21):3309-15. PubMed ID: 23745033
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer.
    Kochi M, Fujii M, Kanamori N, Kaiga T, Takahashi T, Kobayashi M, Takayama T.
    J Cancer Res Clin Oncol; 2006 Dec 07; 132(12):781-5. PubMed ID: 16804723
    [Abstract] [Full Text] [Related]

  • 30. Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy.
    Chen L, Hao Y, Cong X, Zou M, Li S, Zhu L, Song H, Xue Y.
    Technol Cancer Res Treat; 2019 Jan 01; 18():1533033819829485. PubMed ID: 30760114
    [Abstract] [Full Text] [Related]

  • 31. Treatment of locally advanced gastric cancer with the XELOX program of neoadjuvantchemotherapy combined with laparoscopic surgery: the experience in China.
    Zheng CH, Lu J, Huang CM, Li P, Xie JW, Wang JB, Lin JX.
    Hepatogastroenterology; 2014 Oct 01; 61(135):1876-82. PubMed ID: 25713882
    [Abstract] [Full Text] [Related]

  • 32. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
    Xu X, Zheng G, Zhang T, Zhao Y, Zheng Z.
    Cancer Chemother Pharmacol; 2019 Sep 01; 84(3):635-646. PubMed ID: 31230156
    [Abstract] [Full Text] [Related]

  • 33. [Effect of neoadjuvant chemotherapy on nutritional status of locally advanced gastric cancer].
    Deng G, Qu J, Zhai S, Shi Y, Wang X.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar 25; 21(3):331-335. PubMed ID: 29577223
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Exploration of potential beneficial people of neoadjuvant chemotherapy based on clinical staging in gastric cancer: a single center retrospective study].
    Wang YK, Wang YC, Shan F, Tang L, Li ZY, Ji JF.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb 25; 23(2):152-157. PubMed ID: 32074795
    [Abstract] [Full Text] [Related]

  • 37. Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study.
    Su P, Jiang L, Zhang Y, Yu T, Huang H, Chen M, Cao C, Kang W, Liu Y, Yu J.
    Eur J Med Res; 2023 Oct 09; 28(1):409. PubMed ID: 37814327
    [Abstract] [Full Text] [Related]

  • 38. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    Setakornnukul J, Thephamongkhol K.
    BMC Cancer; 2018 Mar 27; 18(1):329. PubMed ID: 29587665
    [Abstract] [Full Text] [Related]

  • 39. A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
    Okabe H, Hata H, Ueda S, Zaima M, Tokuka A, Yoshimura T, Ota S, Kinjo Y, Yoshimura K, Sakai Y, Kyoto University Surgical Oncology Group (KUSOG).
    J Surg Oncol; 2016 Jan 27; 113(1):36-41. PubMed ID: 26604064
    [Abstract] [Full Text] [Related]

  • 40. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
    Tai Q, Shao H, Liu Y, Li E, Zhao R.
    J BUON; 2019 Jan 27; 24(5):2006-2012. PubMed ID: 31786868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.